B
INSM icon

BP’s Insmed INSM Stock Holding History

BP’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,276
Closed -$383K – 449
2017
Q4 		$383K Buy
+12,276
New +$363K 0.01% 431

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

BP's INSM Position: Q1 2018 in Review

BP sold out of Insmed (INSM) in Q1 2018, closing a stake of 12,276 shares — an estimated $383K sold.

BP first reported a position in INSM in Q4 2017 and held it in 1 quarter. The position peaked at $383K in Q4 2017. 127 funds tracked by Wall St. Rank hold INSM as of Q1 2018.

  • BP reported no remaining Insmed position as of Q1 2018 after selling out during the quarter.
  • BP sold 12,276 Insmed shares in Q1 2018, an estimated $383K.
  • BP first reported a position in Insmed in Q4 2017 and held it in 1 quarter.
  • BP's Insmed position peaked at $383K in Q4 2017.
  • 127 funds tracked by Wall St. Rank held Insmed as of Q1 2018.

Based on BP's 13F filing for Q1 2018, filed 26 Apr 2018.